Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
4,244,719
-
Share change
-
+723,649
-
Total reported value
-
$58,616,737
-
Put/Call ratio
-
210%
-
Price per share
-
$13.81
-
Number of holders
-
61
-
Value change
-
+$8,957,096
-
Number of buys
-
40
-
Number of sells
-
24
Institutional Holders of GALECTIN THERAPEUTICS INC - COM NEW (GALT) as of Q2 2014
As of 30 Jun 2014,
GALECTIN THERAPEUTICS INC - COM NEW (GALT) was held by
61 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,244,719 shares.
The largest 10 holders included
Cormorant Asset Management, LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, BAKER BROS. ADVISORS LP, BlackRock Institutional Trust Company, N.A., DAVIDSON D A & CO, State Street Corp, Neuberger Berman Group LLC, Allianz Asset Management AG, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
61
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.